Hongbo Lu, Director at Zenas BioPharma, Inc. (ZBIO), bought 25,985 shares at $22.50 ($585K) on 2026-02-11, disclosed to the SEC on 2026-02-13.
Open-market purchase of $585k ZBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ZBIO | BUY | 2026-03-31 | $1.5M | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |
| TERN | BUY | 2024-09-17 | $5.0M | — | Filing → |